In this scan, we look to identify the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).
Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.
But the scan doesn't just end there.
We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.
Some of the best performers in recent decades – stocks like Priceline, Amazon, Netflix, Salesforce, and myriad others – would have been on this list at some point during their journey to becoming the market behemoths they are today.
When you look at the stocks in our table, you'll notice we're only focused on Technology and Growth industry groups such as Software, Semiconductors, Online...
The biotech market has a great divide between the haves and have-nots. Some stocks have experienced tremendous markup phases, while others can't seem to get out of the doghouse.
Today, we're covering a biotech stock that has rallied nearly 200% this year.
Despite this rally, the short sellers have continued to add to their positions and are close to carrying their largest short position ever.
With the stock coiling at a shelf of former highs from last summer, we're betting the short sellers are on the verge of unwinding their positions and sparking a short squeeze.
With yesterday's market action firing, potentially, another warning shot that Q4 trading will be challenging, I'm on the hunt for opportunities that may be a bit more uncorrelated to the risk I currently have on the books.
One such opportunity is presenting itself in the bond market and we're going to position ourselves to win both in the short-term or the longer-term.
Crypto markets have been trending lower and I have purposefully been putting on very few trades. I think this is the best approach for now while the market sets up.
View this as a positive thing, because while many are losing money and getting emotional, we have the ability to be patient and preserve our capital.
This means that when the good times inevitably return, we can go back to making money rather than clawing back from a drawdown.
These are the registration details for our Live Monthly Candlestick Strategy Session for Premium Members of All Star Charts.
This month’s Video Conference Call will be held on Wednesday September 4th @ 6PM ET. As always, if you cannot make the call live, the video and slides will be archived and published here along with every other live call since 2015.
It's no secret that we're in a bull market for precious metals.
We made the argument for a new secular uptrend for these shiny rocks in last week's Gold Rush video.
Why do we think this is the case?
Gold futures have been printing fresh all-time highs seemingly every day, and precious metals stocks have followed suit with new highs of their own.
When you go back and study the previous cycles you'll notice that every bull market is characterized by more and more stocks making new highs along with the underlying futures contracts.
So let's take a step back and look at some stocks that are making new highs.
Welcome back to Under the Hood, where we'll cover all the action for the two weeks ended August 30, 2024. This report is published bi-weekly, in rotation with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
Click here for a behind-the-scenes look at our process.
Whether we’re measuring increasing interest based on large institutional purchases,...